USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ecole Nationale Veterinaire D'alfort

USPTO PatentsView assignee record - 11 granted patents across 15 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

16.2

Avg claims per patent

-17%

5-year filing velocity

The verdict

Ecole holds 11 US patents across 15 technology areas, rank #24,235 of 50,000 tracked assignees.

#24,235
of 50,000 US assignees by volume: Top 45%
by Innovation Score (37.0/100): 16.2
avg claims per patent: -17%
filing velocity, last 5 yrs

Portfolio overview

Ecole Nationale Veterinaire D'alfort has been granted 11 US utility patents between 2015 and 2024, placing Ecole Nationale Veterinaire D'alfort at rank #24,235 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.2 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a Foreign Corporation, Ecole Nationale Veterinaire D'alfort is one of the more focused assignees in the PatentsView dataset. By volume, Ecole sits between Eagle EYES Traffic IND. Co., Ltd (11 patents, rank #24,231) and EGIS Gyocyszergyar Nyilvanosan Mukodo Reszvenytarsasag (11 patents, rank #24,239) - the closest US assignees by grant volume. The composite Innovation Score of 37.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 6 in the 2015–2019 window, a -17% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Ecole Nationale Veterinaire D'alfort's 16.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 15 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ecole Nationale Veterinaire D'alfort against peers pursuing similar technology classes.

Eagle EYES Traffi…

11
Easel Biotechnolo…

11
EC Power

11
Ecoflow

11
Ecosynthetix

11
Ecovap

11
Effect Photonics…

11
EGIS Gyocyszergya…

11
Ecole Nationale V… ◀

11

What this shows Ecole holds 11 patents at rank #24,235, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Ecole's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

37 Top 45% higher than 55% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Ecole Nationale Veterinaire D'alfort patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	9.1%
2016	2	18.2%
2018	1	9.1%
2019	2	18.2%
2020	1	9.1%
2021	1	9.1%
2022	1	9.1%
2024	2	18.2%

Which technologies does Ecole Nationale Veterinaire D'alfort patent most?

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 5

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 4

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 4

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 3

C07K - PEPTIDES 2

C12Y - ENZYMES 2

A23V - INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION 2

A23L - FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF 2

G01D - MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR 2

H03K - PULSE TECHNIQUE 2

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 2

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 2

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 1

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 1

Top 15 of 15 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#24,235

Across all tracked assignees

Innovation Score

37.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Ecole Nationale Veterinaire D'alfort hold?

Ecole Nationale Veterinaire D'alfort holds 11 US granted patents filed between 2015 and 2024, spanning 15 technology areas.

What is Ecole Nationale Veterinaire D'alfort's Innovation Score?

Ecole Nationale Veterinaire D'alfort has an Innovation Score of 37.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Ecole Nationale Veterinaire D'alfort focus on?

Ecole Nationale Veterinaire D'alfort's top technology area is C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES) with 5 patents. The company has filed patents in 15 CPC subclasses total.

Is Ecole Nationale Veterinaire D'alfort's patent filing rate increasing or decreasing?

Ecole Nationale Veterinaire D'alfort's recent filing velocity is -17% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Ecole Nationale Veterinaire D'alfort's patents?

Ecole Nationale Veterinaire D'alfort's patents average 16.2 claims each. This falls within the standard range, providing solid legal coverage.

How is the Ecole Nationale Veterinaire D'alfort patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Ecole's 11 grants land it in the top 45% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Ecole ranks #24,235 of 50,000. Top 50 holders
Most of this portfolio concentrates in C12Q - see who else leads that technology area. C12Q leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.